{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:27Z","timestamp":1790014827466,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbrc.2013.09.122","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T20:30:50Z","timestamp":1381005050000},"page":"664-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Geraniol attenuates \u03b1-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner"],"prefix":"10.1016","volume":"440","author":[{"given":"Karamkolly R.","family":"Rekha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindasamy P.","family":"Selvakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunanithi","family":"Santha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramu","family":"Inmozhi Sivakamasundari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.09.122_b0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","article-title":"Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson\u2019s disease brain","volume":"21","author":"Chauhan","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bbrc.2013.09.122_b0015","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2013.09.122_b0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-011-0815-1","article-title":"Changes in the solubility and phosphorylation of \u03b1-synuclein over the course of Parkinson\u2019s disease","volume":"121","author":"Zhou","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","article-title":"Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson\u2019s disease","volume":"29","author":"Yokoyama","year":"2008","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244987","article-title":"Astrocytes as a primary locus for the conversion MPTP into MPP+","volume":"76","author":"Brooks","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbrc.2013.09.122_b0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbrc.2013.09.122_b0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0045","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2013.09.122_b0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selectivea-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.09.122_b0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0070","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1248\/bpb.34.1291","article-title":"Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson\u2019s disease","volume":"34","author":"Li","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2013.09.122_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2006.12.011","article-title":"Lipid lowering drugs in the MPTP mouse model of Parkinson\u2019s disease: fenofibrate has a neuroprotective effect, whereas bezofibrate and HMG-CoA reductase inhibitors do not","volume":"1135","author":"Kreisler","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2013.09.122_b0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tiv.2008.12.014","article-title":"Plant derived antioxidants \u2013 geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress","volume":"23","author":"Tiwari","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bbrc.2013.09.122_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-4886(02)00050-X","article-title":"Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function","volume":"180","author":"Robinson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-013-0074-9","article-title":"geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson\u2019s Disease","author":"Rekha","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0095","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2006.01.057","article-title":"Down-regulation of a-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson\u2019s disease rat model","volume":"341","author":"Hayashita-Kinoh","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.09.122_b0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","article-title":"Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism","volume":"123","author":"Tillerson","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbrc.2013.09.122_b0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2013.09.122_b0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2012.05.039","article-title":"Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson\u2019s disease","volume":"218","author":"Anandhan","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2013.09.122_b0120","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1073\/pnas.93.19.10440","article-title":"Rathippocampalneuronsexpress genes for both rod retinal and olfactory cyclic nucleotide-gated channels: novel targets for cAMP\/cGMP function","volume":"93","author":"Kingston","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.09.122_b0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nbd.2011.09.017","article-title":"A30P\u03b1-synuclein impairs dopaminergicfiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice","volume":"45","author":"Szego","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2013.09.122_b0130","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it?","volume":"20","author":"Heikkila","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2013.09.122_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"key":"10.1016\/j.bbrc.2013.09.122_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","article-title":"Oxidative stress in Parkinson\u2019s disease: a mechanism of pathogenic and therapeutic significance","volume":"1147","author":"Zhou","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0145","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fct.2004.08.009","article-title":"Antioxidant properties of black tea in alcohol intoxication","volume":"42","author":"Luczaj","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0150","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","article-title":"Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood\u2013brain barrier monoamine oxidase activity","volume":"84","author":"Kalaria","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.09.122_b0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/abbi.1998.0925","article-title":"Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone","volume":"360","author":"Yoshihara","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2013.09.122_b0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01245973","article-title":"Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson\u2019s disease: a long term study","volume":"64","author":"Birkmayer","year":"1985","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.bbrc.2013.09.122_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0404.1993.tb00019.x","article-title":"Effect of selegiline (deprenyl) on the progression of disability in early Parkinson\u2019s disease, Parkinson Study Group","volume":"146","author":"Shults","year":"1993","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.bbrc.2013.09.122_b0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF01707066","article-title":"Decreased homovanillic acid concentration in the brain in Parkinsonian subjects as an expression of a disorder of central dopamine metabolism","volume":"43","author":"Bernheimer","year":"1965","journal-title":"Klein Wochenschr."},{"key":"10.1016\/j.bbrc.2013.09.122_b0175","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin Wochenschr."},{"key":"10.1016\/j.bbrc.2013.09.122_b0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pbb.2006.02.013","article-title":"The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice","volume":"83","author":"Shepherd","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbrc.2013.09.122_b0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2011.02.027","article-title":"Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"180","author":"Goldberg","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2013.09.122_b0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbrc.2013.09.122_b0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1471-4159.1988.tb13250.x","article-title":"Tyrosine hydroxylase activity in caudate nucleus from Parkinson\u2019s disease: effects of iron and phosphorylating agents","volume":"50","author":"Rausch","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","article-title":"Characterization of a novel protein regulated during the critical period for song learning in the zebra fish","volume":"15","author":"George","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2013.09.122_b0205","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1471-4159.1999.0732586.x","article-title":"Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury","volume":"73","author":"Kholodilov","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0210","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"Van der Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2013.09.122_b0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4049\/jimmunol.132.1.38","article-title":"Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death","volume":"132","author":"Cohen","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells","volume":"16","author":"Galon","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2013.09.122_b0225","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","article-title":"Wild-type but not Parkinson\u2019s disease-related ala-53\u2192Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli","volume":"275","author":"da Costa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0230","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","article-title":"Alpha-Synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt pathway","volume":"16","author":"Seo","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2013.09.122_b0235","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0304-3940(03)00081-8","article-title":"Modulation of cell death by alpha-synuclein is stimulus-dependent in mammalian cells","volume":"340","author":"Zourlidou","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2013.09.122_b0240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cbic.201000604","article-title":"Baicalein inhibits formation of \u03b1-synuclein oligomers within living cells and prevents A\u03b2 peptide fibrillation and oligomerisation","volume":"12","author":"Lu","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbrc.2013.09.122_b0245","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.09.122_b0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.fct.2010.10.029","article-title":"Astaxanthin protects against MPTP\/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro","volume":"49","author":"Lee","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2013.09.122_b0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","article-title":"Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile","volume":"441","author":"Cheng","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2013.09.122_b0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pbb.2011.01.011","article-title":"Baicalein protects the brain against neuron impairments induced by MPTP in C57BL\/6 mice","volume":"98","author":"Mu","year":"2011","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13016276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13016276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T02:10:57Z","timestamp":1688523057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13016276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0006291X13016276"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.122","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geraniol attenuates \u03b1-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}